Sort
51,593 grants matching “hepatitis”
Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity
$543,993Steven William Hetts · University Of California, San Francisco · R01 · FY2015 · CA
Chlamydial Vaccine Testing in Mice and Guinea Pigs
$543,966Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2019 · AI
Nanochelation Therapies for Iron Overload Disorders
$543,904Jonghan Kim · Northeastern University · R01 · FY2019 · HL
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$543,889Iman Osman · New York University School Of Medicine · R01 · FY2019 · CA
Low Dose Interleukin-2 for Regulatory T cell Modulation and the Treatment of CrohnâÂÂs Disease
$543,883Scott B Snapper · Boston Children'S Hospital · R01 · FY2023 · DK
Sterol Regulatory Element Binding Proteins in regulation of lipid metabolism
$543,851Timothy F Osborne · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · HL
CD4+ T Cells in Acute Versus Chronic HCV Infection
$543,750Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2015 · AI
Regulation of hepatic hepcidin expression by transferrin receptor-2
$543,687Caroline Enns · Oregon Health & Science University · R01 · FY2022 · DK
Regulation of hepatic hepcidin expression by transferrin receptor-2
$543,687Caroline Enns · Oregon Health & Science University · R01 · FY2023 · DK
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease
$543,615Yanqiao Zhang · University Of Arizona · R01 · FY2025 · DK
Protective and fibrosis-independent functions of hepatic stellate cells
$543,614Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2021 · DK
The Effects of Oxygen Therapy on Mouse Hepatitis Coronavirus Induced Pneumonia
$543,569Parizad Torabi-Parizi · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Disturbed Crosstalk between Cholesterol Homeostasis and Inflammation Resolution in NASH
$543,526Bishuang Cai · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
HBV Capsid Effectors
$543,503Raymond F. Schinazi · Emory University · R01 · FY2018 · AI
Molecular & cellular mechanisms of hepatocellular polarity and biliary secretion
$543,465Irwin Arias · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
$543,455Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2022 · ES
Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome
$543,446Melanie G Cree · University Of Colorado Denver · R01 · FY2021 · DK
Atherogenic Patheways Mediated by FOXO
$543,434Domenico Accili · Columbia University Health Sciences · P01 · FY2008 · HL
Atherogenic Patheways Mediated by FOXO
$543,434Domenico Accili · Columbia University Health Sciences · P01 · FY2011 · HL
Atherogenic Patheways Mediated by FOXO
$543,434Domenico Accili · Columbia University Health Sciences · P01 · FY2010 · HL
Atherogenic Patheways Mediated by FOXO
$543,434Domenico Accili · Columbia University Health Sciences · P01 · FY2009 · HL
Host response and liver disease in a hepatitis C-like virus rat model
$543,426Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2018 · AI
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$543,352Ira A Tabas · Columbia University Health Sciences · P01 · FY2017 · HL
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$543,352Ira A Tabas · Columbia University Health Sciences · P01 · FY2016 · HL
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$543,351Ira A Tabas · Columbia University Health Sciences · P01 · FY2013 · HL